EP Patent

EP1542662A1 — Immediate release dosage form comprising shell having openings therein

Assigned to Kenvue Brands LLC · Expires 2005-06-22 · 21y expired

What this patent protects

The invention provides an immediate release dosage form having a solid core and a shell readily soluble in gastrointestinal fluids. The dosage form also comprises one or more openings in the shell.

USPTO Abstract

The invention provides an immediate release dosage form having a solid core and a shell readily soluble in gastrointestinal fluids. The dosage form also comprises one or more openings in the shell.

Drugs covered by this patent

Patent Metadata

Patent number
EP1542662A1
Jurisdiction
EP
Classification
—
Expires
2005-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Kenvue Brands LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.